Rebekah Margaret Samsonraj

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI High Impact

Role not yet determined Is this you? Add your title

University of Arkansas primary UAMS

Also affiliated: Agency for Science, Technology and Research (2013–2020); Beijing Tongren Hospital (2020); Mayo Clinic (2015–2025); National University of Singapore (2013–2017); University of Oregon (2020); Capital Medical University (2020); Institute of Medical Biology (2013–2020)

22 h-index 45 pubs 2,303 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website

OverviewAI-generated summary

Rebekah Margaret Samsonraj's research focuses on mesenchymal stem cells (MSCs) and their potential applications in regenerative medicine and cellular therapy. She has investigated the multifaceted characterization of human MSCs to establish criteria for their potency and has explored the biological effects of compounds like melatonin on bone metabolism, including osteoblastogenesis and osteoclastogenesis. Her work has also examined the role of specific cellular structures and proteins, such as intranuclear actin and Enhancer of zeste homolog 2 (Ezh2), in modulating MSC differentiation and osteogenesis in animal models.

Dr. Samsonraj has received federal funding, including a $466,266 NSF grant for biophysical modulation in the biomanufacturing of stem cell-derived therapeutics. Her publication record includes work on lipid-based nanoparticles for cancer treatment and a translational study on melatonin and micronutrients for osteopenia in postmenopausal women. Her scholarship metrics include an h-index of 22 and over 2,400 citations across 46 publications. She collaborates with researchers at the University of Arkansas at Fayetteville and the University of Arkansas for Medical Sciences.

Metrics

h-index: 22
Publications: 45
Citations: 2,303

Selected Publications

A Review of Rejuvenation Strategies Targeting Mesenchymal Stem Cell Senescence and Their Impact on Bone Health and Regeneration (2026)

Current Osteoporosis Reports DOI OpenAlex
Combined senolytics induce varied phenotypic and functional responses on senescent phenotypes of mesenchymal stromal cell populations (2026)

Biochimie 1 citation DOI OpenAlex
Validation of a novel genomic biomarker of mesenchymal stem cell scalability and implications of genotype status on cellular senescence phenotypes (2026)

Scientific Reports DOI OpenAlex
Validation of a Novel Genomic Biomarker of Mesenchymal Stem Cell Scalability and Implications of Genotype Status on Cellular Senescence Phenotypes (2025)

Research Square DOI OpenAlex
Examining the Effects of Quercetin on Phenotypic Characteristics of Human Mesenchymal Stem Cells (2025)

Cellular and Molecular Bioengineering 5 citations DOI OpenAlex
Phenotypic changes associated with continuous long term in vitro expansion of bone marrow-derived mesenchymal stem cells (2025)

Biochimie 7 citations DOI OpenAlex
Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells (2024)

Cellular and Molecular Bioengineering DOI OpenAlex
Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells (2024)

Cellular and Molecular Bioengineering 7 citations DOI OpenAlex
Phenotypic and Functional Characterization of Bovine Adipose-Derived Mesenchymal Stromal Cells (2024)

Animals 11 citations DOI OpenAlex
Phenotypic and functional characterization of bovine adipose-derived mesenchymal stromal cells (2024)

Research Square DOI OpenAlex
Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy (2023)

Journal of Biological Engineering 115 citations DOI OpenAlex
Versatility of mesenchymal stem cell-derived extracellular vesicles in tissue repair and regenerative applications (2022)

Biochimie 68 citations DOI OpenAlex
OSTEOIMMUNOLOGICAL IMPLICATIONS IN REGENERATIVE MEDICINE: CROSS-TALK BETWEEN MESENCHYMAL STEM CELLS AND IMMUNE CELLS (2020)

Journal of Musculoskeletal Research DOI OpenAlex